Hospitalization and surgery rates in patients with infammatory bowel disease in Brazil: a time-trend analysis
Visceral fat is increased in individuals with Crohn’s disease: a comparative analysis with healthy controls
Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn’s Disease and Individuals with Obesity Before and After Bariatric Surgery
Percepção e atitude de prescritores frente ao posicionamento de novas terapias para o tratamento da Doença Inflamatória Intestinal
Vedolizumab in the management of inflammatory bowel diseases: a Brazilian observational multicentric study
Remission in crohn’s disease is accompanied by alterations in the gut microbiota and mucins production
Novidade no Componente Especializado da Assistência Farmacêutica: Mesalazina Sachê Disponível para Aquisição novembro 4, 2024
